Xylem Inc. (NYSE:XYL) Shares Bought by abrdn plc

abrdn plc grew its position in shares of Xylem Inc. (NYSE:XYLFree Report) by 15.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 811,295 shares of the industrial products company’s stock after acquiring an additional 109,918 shares during the quarter. abrdn plc owned about 0.34% of Xylem worth $92,780,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Bruce G. Allen Investments LLC acquired a new stake in Xylem in the fourth quarter worth about $27,000. Coppell Advisory Solutions LLC acquired a new stake in Xylem in the second quarter worth about $45,000. KB Financial Partners LLC acquired a new stake in Xylem in the first quarter worth about $42,000. NBC Securities Inc. acquired a new stake in Xylem in the third quarter worth about $38,000. Finally, Orion Capital Management LLC acquired a new stake in Xylem in the third quarter worth about $48,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Citigroup upped their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Oppenheimer upped their price objective on shares of Xylem from $133.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday. Robert W. Baird boosted their price target on shares of Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research report on Thursday, March 21st. Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. Finally, Royal Bank of Canada boosted their price target on shares of Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 7th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $138.11.

Read Our Latest Report on Xylem

Insider Activity

In other news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Xylem Price Performance

NYSE XYL opened at $127.84 on Friday. The stock’s 50-day moving average price is $127.01 and its two-hundred day moving average price is $112.52. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. The company has a market cap of $30.99 billion, a PE ratio of 47.00, a PEG ratio of 2.55 and a beta of 1.10. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $130.86.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The business’s revenue for the quarter was up 40.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.92 EPS. On average, analysts predict that Xylem Inc. will post 4.13 EPS for the current year.

Xylem Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were issued a $0.36 dividend. This is an increase from Xylem’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, February 20th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.13%. Xylem’s dividend payout ratio is currently 52.94%.

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.